Home » Abiomed Gets Conditional Approval for Study on Reducing Heart Muscle Damage
Abiomed Gets Conditional Approval for Study on Reducing Heart Muscle Damage
Abiomed, Inc. … Thursday announced it has received conditional approval from the U.S. Food and Drug Administration to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May